¼¼°èÀÇ »ê¾÷¿ë, ÀüÀÓ»ó¿ë, ÀÓ»ó¿ë ¾Æ¹Ì³ë»ê ºÐ¼®°è ½ÃÀå
Amino Acid Analyzers for Industrial, Preclinical and Clinical Usage
»óǰÄÚµå : 1757968
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 270 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,068,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,204,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ »ê¾÷¿ë, ÀüÀÓ»ó¿ë, ÀÓ»ó¿ë ¾Æ¹Ì³ë»ê ºÐ¼®°è ½ÃÀåÀº 2030³â±îÁö 1¾ï 3,880¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 1¾ï 1,020¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ »ê¾÷¿ë, ÀüÀÓ»ó¿ë, ÀÓ»ó¿ë ¾Æ¹Ì³ë»ê ºÐ¼®°è ½ÃÀåÀº 2024-2030³â¿¡ CAGR 3.9%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 1¾ï 3,880¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®µÇ°í ÀÖ´Â ºÎ¹®ÀÇ ÇϳªÀÎ ÀÚµ¿Àº CAGR 3.2%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 8,280¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼öµ¿ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 5.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3,000¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ »ê¾÷¿ë, ÀüÀÓ»ó¿ë, ÀÓ»ó¿ë ¾Æ¹Ì³ë»ê ºÐ¼®°è ½ÃÀåÀº 2024³â¿¡ 3,000¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 7.1%·Î ÃßÀÌÇϸç, 2030³â¿¡´Â ¿¹Ãø ½ÃÀå ±Ô¸ð 2,790¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 1.6%¿Í 3.0%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¾Æ¹Ì³ë»ê ºÐ¼®±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¾Æ¹Ì³ë»ê ºÐ¼®±â°¡ »ê¾÷, ÀüÀÓ»ó, ÀÓ»ó ºÐ¾ß¿¡¼­ ¿Ö Áß¿äÇѰ¡?

¾Æ¹Ì³ë»ê ºÐ¼®±â´Â Á¦¾à ¹× ÀÓ»ó Áø´Ü¿¡¼­ ½Äǰ °úÇÐ ¹× »ê¾÷ Á¦Á¶¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ÇʼöÀûÀÎ Åø·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ±× ÇÙ½É ±â´ÉÀº »ý¹°ÇÐÀû »ùÇà ¶Ç´Â ÇÕ¼º »ùÇÿ¡¼­ ¾Æ¹Ì³ë»êÀ» Ź¿ùÇÑ Á¤È®µµ·Î ºÐ¸®, °ËÃâ ¹× Á¤·®ÇÏ´Â °ÍÀÔ´Ï´Ù. ¾Æ¹Ì³ë»êÀº ´ë»ç, ´Ü¹éÁú ÇÕ¼º ¹× Áúº´ ÁøÇà¿¡ ÇÙ½ÉÀûÀÎ ¿ªÇÒÀ» Çϸç, Á¤È®ÇÑ ÃøÁ¤Àº °Ç°­°ú ǰÁú°ü¸® Ãø¸é¿¡¼­ ¸Å¿ì Áß¿äÇϹǷΠÀÌ ´É·ÂÀº ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÓ»ó ºÐ¾ß¿¡¼­ ¾Æ¹Ì³ë»ê ºÐ¼®±â´Â ´ë»çÀÌ»ó Áø´Ü, ¿µ¾ç »óÅ ¸ð´ÏÅ͸µ, ƯÈ÷ ¼±Ãµ¼º ´ë»çÀÌ»ó°ú °ü·ÃµÈ °æ¿ì ½ÄÀÌ ÁßÀ縦 ¾È³»ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ÀüÀÓ»ó ¿¬±¸¿¡¼­´Â µ¿¹° ¸ðµ¨¿¡¼­ ¾Æ¹Ì³ë»ê ÇÁ·ÎÆÄÀÏÀÇ º¯È­¸¦ ¹àÇô³»¾î ¾à¹°ÀÇ È¿´É°ú µ¶¼ºÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. »ê¾÷ÀûÀ¸·Î´Â ¾Æ¹Ì³ë»ê º¸ÃæÁ¦, ¹ßÈ¿ °øÁ¤, ½Äǰ ¹× À½·á Á¦Á¶¿¡¼­ ´Ü¹éÁú °¡¼öºÐÇØ¹°ÀÇ Ç°Áú º¸Áõ¿¡ »ç¿ëµË´Ï´Ù. ±× À¯¿ë¼ºÀº ¾Æ¹Ì³ë»ê ÇÁ·ÎÆÄÀÏÀÌ Á¾ÀÚÀÇ Ç°Áú°ú °¡ÃàÀÇ ¿µ¾ç ó¹æ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ³ó¾÷ »ý¸í°øÇÐ ºÐ¾ß·Î±îÁö È®´ëµÇ°í ÀÖ½À´Ï´Ù. ³ôÀº 󸮷®, °í°¨µµ, ÀçÇö¼º ÀÖ´Â ºÐ¼®¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¾Æ¹Ì³ë»ê ºÐ¼®±â´Â ÀÚµ¿È­µÈ ½Ã·á ó¸® ¹× ÷´Ü Å©·Î¸¶Åä±×·¡ÇÇ ±â¼ú°ú ÅëÇÕµÇ¾î ´õ¿í Á¤±³ÇØÁö°í ÀÖ½À´Ï´Ù. Á¤¹Ð °Ç°­, ½Äǰ ¾ÈÀü, ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÃÖÀûÈ­°¡ Àü ¼¼°è¿¡¼­ Á߿伺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó ±× ºÐ¾ß °£ ¿¬°ü¼ºÀº °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀº ¾Æ¹Ì³ë»ê ºÐ¼®ÀÇ È¿À²¼º°ú Á¤È®¼ºÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

ÃÖ±Ù ±â¼ú Çõ½ÅÀº ¾Æ¹Ì³ë»ê ºÐ¼®±âÀÇ ¼³°è¿Í ´É·ÂÀ» Å©°Ô º¯È­½ÃÄÑ ÀÌÀüº¸´Ù ´õ ºü¸£°í, Á¤È®Çϰí, »ç¿ëÇϱ⠽±°Ô ¸¸µé¾ú½À´Ï´Ù. ±ä ºÐ¼® ½Ã°£°ú ¼öÀÛ¾÷¿¡ ÀÇÇÑ ½Ã·á Áغñ¿¡ ÀÇÁ¸ÇÏ´Â °æ¿ì°¡ ¸¹¾Ò´ø ±âÁ¸ ºÐ¼®±â´Â °í¼Ó ¾×ü Å©·Î¸¶Åä±×·¡ÇÇ(HPLC), Ãʰí¼Ó ¾×ü Å©·Î¸¶Åä±×·¡ÇÇ(UPLC), ÀÚµ¿ À¯µµÃ¼È­ ±â¼ú µîÀÇ ±â´ÉÀ» ÅëÇØ ¾÷±×·¹À̵åµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¼±À¸·Î ºÐ¼® ½Ã°£ÀÌ ´ÜÃàµÇ¾úÀ» »Ó¸¸ ¾Æ´Ï¶ó ºÐ¸®´É°ú °ËÃâ °¨µµ°¡ Çâ»óµÇ¾î ¾Æ¹Ì³ë»ê ³óµµ°¡ ³·°Å³ª º¹ÀâÇÑ ¸ÅÆ®¸¯½ºÀÇ »ùÇÿ¡ ÇʼöÀûÀÔ´Ï´Ù. Çü±¤ °ËÃâ±â ¹× Áú·®ºÐ¼® °ËÃâ±â¿ÍÀÇ ÅëÇÕÀÌ º¸ÆíÈ­µÇ¾î ¾Ë·ÁÁø ¾Æ¹Ì³ë»ê°ú Èñ±Í ¾Æ¹Ì³ë»ê ¸ðµÎ¿¡ ´ëÇÑ °ËÃâ ÇѰè¿Í ƯÀ̼ºÀÌ È®´ëµÇ¾ú½À´Ï´Ù. »õ·Î¿î ±â±â¿¡´Â ½Ç½Ã°£ ¸ð´ÏÅ͸µ, ÀÚµ¿ µ¥ÀÌÅÍ ºÐ¼®, ½ÇÇè½Ç Á¤º¸ ½Ã½ºÅÛ(LIS)°úÀÇ ¿øÈ°ÇÑ ÅëÇÕÀ» °¡´ÉÇÏ°Ô ÇÏ´Â AI ±â¹Ý ¼ÒÇÁÆ®¿þ¾î Ç÷§ÆûÀÌ Å¾ÀçµÇ¾î ÀÖÀ¸¸ç, ¿öÅ©Ç÷οìÀÇ È¿À²¼ºÀ» ³ôÀ̰í ÀÛ¾÷ÀÚÀÇ ½Ç¼ö¸¦ ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸ðµâ½Ä ½Ã½ºÅÛÀ» ÅëÇØ ½ÇÇè½ÇÀº ½Ã·áÀÇ ¾ç°ú º¹À⼺¿¡ µû¶ó ±â´ÉÀ» È®ÀåÇÒ ¼ö ÀÖÀ¸¸ç, °í󸮷® »ê¾÷ ½ÇÇè½ÇÀ̳ª Àü¹® ÀÓ»ó ¿¬±¸½Ã¼³¿¡ ½±°Ô ÀûÀÀÇÒ ¼ö ÀÖÀ¸¸ç, IoT ±â¼úÀ» ÅëÇØ ¿ø°Ý Áø´Ü ¹× À¯Áöº¸¼ö ±â´Éµµ °¡´ÉÇØÁ³½À´Ï´Ù. ¿ø°Ý Áø´Ü ¹× À¯Áöº¸¼ö ±â´Éµµ µîÀåÇÏ¿© °¡µ¿ ½Ã°£°ú ÀåºñÀÇ ¼ö¸íÁֱ⸦ °³¼±Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ¾Æ¹Ì³ë»ê ºÐ¼® ºÐ¾ß¿¡¼­ »õ·Î¿î ¼º´É Ç¥ÁØÀ» ¼³Á¤Çϰí, ºÐ¼® ¼ö¿ä¿Í µ¥ÀÌÅÍ º¹À⼺ÀÌ Áõ°¡ÇÏ´Â ½Ã´ë¿¡ Áö¼ÓÀûÀÎ À¯È¿¼º°ú ÀûÀÀ¼ºÀ» º¸ÀåÇÕ´Ï´Ù.

¾Æ¹Ì³ë»ê ºÐ¼®±â º¸±ÞÀ» ÃËÁøÇÏ´Â ½ÃÀå µ¿Çâ°ú ±ÔÁ¦ µ¿ÇâÀº?

¼¼°èÀÇ ¾Æ¹Ì³ë»ê ºÐ¼®±â ½ÃÀåÀº ÁøÈ­ÇÏ´Â ±ÔÁ¦, Áõ°¡ÇÏ´Â ÀÓ»óÀû ¿ä±¸, ¿µ¾ç Åõ¸í¼º ¹× ǰÁú°ü¸®¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ ¿ä±¸·Î ÀÎÇØ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ºÐ¾ß¿¡¼­´Â ´ë»çÁõÈıº, ¸¸¼ºÁúȯ, ´Ü¹éÁú ¿¡³ÊÁö ¿µ¾ç½ÇÁ¶ À¯º´·ü Áõ°¡·Î ÀÎÇØ ¾Æ¹Ì³ë»ê ÇÁ·ÎÆÄÀϸµÀ» Æ÷ÇÔÇÑ º¸´Ù Á¾ÇÕÀûÀÎ Áø´Ü ÅøÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ¸¹Àº ±¹°¡ÀÇ ±ÔÁ¦±â°üÀº Ç¥ÁØÈ­µÈ Áø´Ü ÇÁ·ÎÅäÄݰú ´ë»ç¼º Áúȯ¿¡ ´ëÇÑ º¸´Ù È®½ÇÇÑ µ¥ÀÌÅ͸¦ ¿ä±¸Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ÀÓ»óÀûÀ¸·Î °ËÁõµÈ ºÐ¼® Àåºñ¿¡ ´ëÇÑ ÅõÀÚÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÇÑÆí, ½Äǰ ¹× °Ç°­ º¸Á¶ ½Äǰ ¾÷°è´Â Á¦Ç°ÀÇ ¾ÈÀü¼º, ½Å·Ú¼º ¹× ¿µ¾ç °­Á¶ Ç¥½Ã¸¦ º¸ÀåÇØ¾ß ÇÑ´Ù´Â ¾Ð¹Ú¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÌÀ¯·Î ´Ü¹éÁú ǰÁú È®ÀÎ, ºÒ¼ø¹° °ËÃâ, Á¦Á¶ Àϰü¼º ¸ð´ÏÅ͸µÀ» À§ÇØ ¾Æ¹Ì³ë»ê ºÐ¼®±â°¡ ³Î¸® µµÀԵǰí ÀÖ½À´Ï´Ù. Á¦¾à ±â¾÷µµ ¾Æ¹Ì³ë»ê ÇÁ·ÎÆÄÀϸµÀ» ÀǾàǰ °³¹ß ¹× ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÃÖÀûÈ­¿¡ µµÀÔÇϰí ÀÖÀ¸¸ç, ¾Æ¹Ì³ë»ê ³óµµÀÇ ÀÛÀº ÆíÂ÷µµ Ä¡·á °á°ú¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. Çаè¿Í Á¤ºÎ ¿¬±¸ ±â°ü¿¡¼­´Â ¿µ¾ç °úÇаú ¸ÂÃã ÀÇ·á¿¡ ´ëÇÑ ÀÚ±Ý Áö¿øÀ¸·Î Áý´Ü ¿¬±¸¿Í ½ÇÇè ¸ðµ¨ ¸ðµÎ¿¡¼­ °íÇØ»óµµ ¾Æ¹Ì³ë»ê ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ISO ¹× WHO¿Í °°Àº ±¹Á¦ Ç¥ÁØÀº ½Äǰ ¶óº§¸µ°ú ÀÓ»ó Áø´Ü¿¡¼­ Á¤È®ÇÑ ¾Æ¹Ì³ë»ê ÃøÁ¤¿¡ ´ëÇÑ Á߿伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ÄÄÇöóÀ̾𽺠Áß½ÉÀÇ ºÐ¼®±â µµÀÔ¿¡ ´ëÇÑ Àμ¾Æ¼ºê°¡ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. Àü ¼¼°è °Ç°­°ú ¿µ¾çÀÇ ¿ì¼±¼øÀ§°¡ °è¼Ó ÁøÈ­ÇÔ¿¡ µû¶ó Á¤È®ÇÑ »ýÈ­ÇÐ µ¥ÀÌÅÍ¿¡ ´ëÇÑ Çʿ伺ÀÌ Á¡Á¡ ´õ Ä¿Áú °ÍÀ̸ç, ¾Æ¹Ì³ë»ê ºÐ¼®±â´Â Çö´ë °úÇÐ ¹× »ê¾÷ ÀÎÇÁ¶ó¿¡ ´Ü´ÜÈ÷ ÅëÇÕµÉ °ÍÀÔ´Ï´Ù.

¼¼°è ¾Æ¹Ì³ë»ê ºÐ¼®±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?

¿©·¯ ÃËÁø¿äÀÎÀÌ ¾Æ¹Ì³ë»ê ºÐ¼®±â±â ¼¼°è ½ÃÀå È®´ë¸¦ °ßÀÎÇϰí ÀÖÀ¸¸ç, ÀÌ´Â »ê¾÷, ÀÓ»ó ¹× ÀüÀÓ»ó ºÐ¾ß¿¡¼­ ¾Æ¹Ì³ë»ê ºÐ¼®±â±âÀÇ Á߿伺ÀÌ Áõ°¡Çϰí ÀÖÀ½À» Áö¿øÇÕ´Ï´Ù. °¡Àå À¯·ÂÇÑ ÃËÁø¿äÀÎ Áß Çϳª´Â ¾Æ¹Ì³ë»ê ÇÁ·ÎÆÄÀϸµÀÌ ½Ä´Ü, Ä¡·á ¹× ¿¹¹æ Àü·«À» Á¶Á¤ÇÏ´Â µ¥ ÀÖÀ¸¸ç, ¾Æ¹Ì³ë»ê ÇÁ·ÎÆÄÀϸµÀÌ ¸Å¿ì Áß¿äÇÑ °³ÀÎ ¸ÂÃãÇü ÇコÄɾ ´ëÇÑ Àü ¼¼°èÀûÀÎ °ü½ÉÀÔ´Ï´Ù. Áø´Ü ¹× °ü¸®¸¦ À§ÇØ Á¤¹ÐÇÑ ¾Æ¹Ì³ë»ê ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ ´ë»ç¼º ¹× À¯Àü¼º Áúȯ Áõ°¡·Î ÀÎÇØ º´¿ø ¹× Áø´Ü ½ÇÇè½Ç¿¡¼­ ºÐ¼® ÀåºñÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÇÑÆí, Á¦¾à »ê¾÷¿¡¼­´Â »ý¹°Á¦Á¦ ¹× Á¤¹Ð Á¦Á¦ÀÇ ÃßÁøÀ¸·Î °³¹ß ¹× Á¦Á¶ÀÇ °¢ ´Ü°è¿¡¼­ ǰÁú°ú Àϰü¼ºÀ» º¸ÀåÇÒ ¼ö ÀÖ´Â ºÐ¼® Àåºñ¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½Äǰ ¹× À½·á ºÐ¾ß¿¡¼­´Â Ŭ¸° ¶óº§ µ¿Çâ°ú ±ÔÁ¦ ´ç±¹ÀÇ °¨½Ã·Î ÀÎÇØ ±â¾÷ÀÌ ´Ü¹éÁú ÇÔ·®°ú ¼ººÐÀ» °ËÁõÇϰí ÀÖÀ¸¸ç, ¿µ¾ç °ËÁõ¿¡¼­ ºÐ¼®±âÀÇ ¿ªÇÒÀÌ °­È­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹«¿ª ¹× °ø±Þ¸ÁÀÇ ¼¼°èÈ­´Â ½Äǰ, »ç·á ¹× ÀǾàǰÀÌ ¾ö°ÝÇÑ ±¹Á¦ Å×½ºÆ® Ç¥ÁØÀ» ÃæÁ·ÇØ¾ß ÇÔÀ» ÀǹÌÇϸç, ǰÁú º¸Áõ ½ÇÇè½Ç¿¡ ºÐ¼®±â¸¦ µµÀÔÇÏ´Â °ÍÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ ¾Æ¹Ì³ë»ê ºÐ¼®ÀÇ ºñ¿ë°ú º¹À⼺ÀÌ °¨¼ÒÇÔ¿¡ µû¶ó Áß¼Ò±Ô¸ðÀÇ ½ÇÇè½Ç¿¡¼­µµ °ú°Å¿¡´Â ´ë±Ô¸ð ¿¬±¸¼Ò¿¡¸¸ ±¹ÇѵǾú´ø °íÁ¤¹Ð Åø¿¡ ÅõÀÚÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¸¶Áö¸·À¸·Î ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­ÀÇ R&D ÀÚ±ÝÀÇ È®´ë´Â ÀÌ·¯ÇÑ ±â±âÀÇ °í°´ ±â¹ÝÀ» ³ÐÇô Àü ¼¼°è¿¡¼­ Áö¼ÓÀûÀÎ ¼ºÀåÀ» ½Ã»çÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεé·Î ÀÎÇØ ¾Æ¹Ì³ë»ê ºÐ¼®±â´Â ±¤¹üÀ§ÇÑ ¿ëµµ¿¡¼­ ÇʼöÀûÀÎ Åø·Î ÀÚ¸®¸Å±èÇϰí ÀÖÀ¸¸ç, ºü¸£°Ô º¯È­ÇÏ´Â °úÇÐ ¹× ±ÔÁ¦ ȯ°æ¿¡¼­ Áö¼ÓÀûÀÎ ¼ö¿ä¸¦ º¸ÀåÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

À¯Çü(ÀÚµ¿, ¼öµ¿), ¾ÖÇø®ÄÉÀ̼Ç(ÀÓ»ó¡¤ÀǾàǰ ¾ÖÇø®ÄÉÀ̼Ç, ½Äǰ ¹× À½·á ¾ÖÇø®ÄÉÀ̼Ç, ±âŸ ¾ÖÇø®ÄÉÀ̼Ç)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 36»ç)

AI ÅëÇÕ

¿ì¸®´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Amino Acid Analyzers for Industrial, Preclinical and Clinical Usage Market to Reach US$138.8 Million by 2030

The global market for Amino Acid Analyzers for Industrial, Preclinical and Clinical Usage estimated at US$110.2 Million in the year 2024, is expected to reach US$138.8 Million by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Automatic, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$82.8 Million by the end of the analysis period. Growth in the Manual segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$30.0 Million While China is Forecast to Grow at 7.1% CAGR

The Amino Acid Analyzers for Industrial, Preclinical and Clinical Usage market in the U.S. is estimated at US$30.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.9 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Amino Acid Analyzers Market - Key Trends & Drivers Summarized

Why Are Amino Acid Analyzers Vital Across Industrial, Preclinical, and Clinical Fields?

Amino acid analyzers serve as indispensable tools across a wide array of sectors-ranging from pharmaceuticals and clinical diagnostics to food science and industrial manufacturing. Their core function is to separate, detect, and quantify amino acids in biological or synthetic samples with exceptional accuracy. This ability is critical because amino acids play central roles in metabolism, protein synthesis, and disease progression, making their precise measurement essential for both health and quality control purposes. In the clinical realm, amino acid analyzers are used to diagnose metabolic disorders, monitor nutritional status, and guide dietary interventions, particularly in cases involving inborn errors of metabolism. In preclinical research, they help evaluate drug efficacy and toxicity by revealing shifts in amino acid profiles in animal models. Industrially, these analyzers are used in quality assurance for amino acid supplements, fermentation processes, and protein hydrolysates in food and beverage manufacturing. Their utility extends even to agricultural biotechnology, where amino acid profiles influence seed quality and livestock nutrition formulations. Given the increasing demand for high-throughput, sensitive, and reproducible analysis, amino acid analyzers are becoming more sophisticated, often integrated with automated sample handling and advanced chromatographic techniques. Their cross-sectoral relevance continues to grow as precision health, food security, and bioprocess optimization gain greater global importance.

How Are Technological Innovations Enhancing Amino Acid Analysis Efficiency and Precision?

Recent technological advancements are significantly reshaping the design and capability of amino acid analyzers, making them faster, more accurate, and easier to use than ever before. Traditional analyzers, which often relied on long analysis times and manual sample preparation, have been upgraded with features like high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), and automated derivatization techniques. These improvements not only reduce analysis time but also improve separation resolution and detection sensitivity-critical for samples with low amino acid concentrations or complex matrices. Integration with fluorescence and mass spectrometry detectors is now common, expanding the detection limits and specificity for both known and rare amino acids. Newer instruments are also equipped with AI-driven software platforms that allow for real-time monitoring, automated data interpretation, and seamless integration with laboratory information systems (LIS), boosting workflow efficiency and minimizing operator error. Moreover, modular systems now allow labs to scale their capabilities based on sample volume and complexity, making these analyzers more adaptable for both high-throughput industrial labs and specialized clinical research facilities. Remote diagnostics and maintenance features, enabled by IoT technologies, have also emerged, improving uptime and instrument lifecycle. These advancements are setting new performance standards in the field of amino acid analysis, ensuring its continued relevance and adaptability in an era of increasing analytical demand and data complexity.

What Market and Regulatory Trends Are Driving the Widespread Adoption of Amino Acid Analyzers?

The global market for amino acid analyzers is being shaped by evolving regulations, growing clinical needs, and broader demands for nutritional transparency and quality control. In healthcare, the increasing incidence of metabolic syndromes, chronic diseases, and protein-energy malnutrition has necessitated more comprehensive diagnostic tools that include amino acid profiling. Regulatory bodies in many countries are pushing for standardized diagnostic protocols and more robust data for metabolic disorders, which has driven investments in clinically validated analyzers. Meanwhile, food and nutraceutical industries face mounting pressure to ensure the safety, authenticity, and nutritional claims of their products. This has led to wider deployment of amino acid analyzers for verifying protein quality, detecting adulteration, and monitoring manufacturing consistency. Pharmaceutical companies are also incorporating amino acid profiling into drug development and bioprocess optimization, where even minor deviations in amino acid concentrations can affect therapeutic outcomes. In academic and government research institutions, funding for nutritional science and personalized medicine has boosted demand for high-resolution amino acid analysis in both population studies and experimental models. International standards, such as those from the ISO and WHO, now emphasize accurate amino acid measurement in food labeling and clinical diagnostics, creating a compliance-driven incentive for analyzer adoption. As global health and nutrition priorities continue to evolve, the need for precise biochemical data will only intensify, firmly embedding amino acid analyzers into the infrastructure of modern science and industry.

What Are the Key Drivers Propelling Growth in the Amino Acid Analyzers Market Globally?

Multiple converging drivers are propelling the expansion of the global amino acid analyzers market, underscoring its growing significance across industrial, clinical, and preclinical domains. One of the most compelling drivers is the global emphasis on personalized healthcare, where amino acid profiling is crucial for tailoring diets, therapies, and preventive strategies. The rise of metabolic and genetic disorders, which often require precise amino acid monitoring for diagnosis and management, has increased analyzer use in hospitals and diagnostic labs. Meanwhile, the pharmaceutical industry’s push for biologics and precision drug formulation has created a robust need for analyzers that can ensure quality and consistency at every stage of development and production. In the food and beverage sector, clean-label trends and regulatory scrutiny are encouraging companies to verify protein content and composition, reinforcing the role of analyzers in nutritional validation. Furthermore, the globalization of trade and supply chains means food, feed, and drug products must meet rigorous international testing standards-fueling analyzer deployment in quality assurance labs. Advances in technology have lowered the cost and complexity of amino acid analysis, allowing small and mid-sized labs to invest in high-precision tools that were once limited to large research centers. Lastly, expanding R&D funding, especially in emerging markets, is broadening the customer base for these instruments, signaling sustained global growth. These drivers collectively position amino acid analyzers as essential tools in a wide spectrum of applications, ensuring their enduring demand in a rapidly changing scientific and regulatory landscape.

SCOPE OF STUDY:

The report analyzes the Amino Acid Analyzers for Industrial, Preclinical and Clinical Usage market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Automatic, Manual); Application (Clinical & Pharmaceuticals Application, Food & Beverages Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â